Code

Description

00

None, disease free

01

In situ

06

Recurrence following diagnosis of an in situ lesion of the same site

10

Local

11

Trocar site

15

Combination of 10 and 11

16

Local recurrence following an in situ lesion of the same site

17

Combination of 16 with 10, 11 and/or 15

20

Regional, NOS

21

Regional tissue

22

Regional lymph nodes

25

Combination of 21 and 22

26

Regional recurrence following an in situ lesion of the same site

27

Combination of 26 with 21, 22, and/or 25

30

Any combination of 10, 11, and 20, 21 or 22

36

Any combination of recurrence following an in situ lesion of the same site with 10, 11, 20, 21 or 22

40

Distant recurrence, and there is insufficient information available to code to 46-62

46

Distant recurrence of an in situ tumor

51

Distant recurrence of invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid.

52

Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura.

53

Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid.

54

Distant recurrence of an invasive tumor in the liver only.

55

Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site.

56

Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye.

57

Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site.

58

Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site.

59

Distant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, generalized disease.

60

Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar and/or regional recurrence (10-15, 20-25, or 30).

62

Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59).

70

Since diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated.

88

Disease has recurred, but the type of recurrence is unknown

99

It is unknown whether the disease has recurred or if the patient was ever disease-free